Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells

Molecular characterization is currently a key step in NSCLC therapy selection. Circulating tumor cells (CTC) are excellent candidates for downstream analysis, but technology is still lagging behind. In this work, we show that the mutational status of NSCLC can be assessed on hypermetabolic CTC, dete...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Turetta, Matteo, Bulfoni, Michela, Brisotto, Giulia, Fasola, Gianpiero, Zanello, Andrea, Biscontin, Eva, Mariuzzi, Laura, Steffan, Agostino, Di Loreto, Carla, Cesselli, Daniela, Del Ben, Fabio
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6115779/
https://ncbi.nlm.nih.gov/pubmed/30110953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10080270
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы